BPC-157 and IGF-1 LR3 Interaction

Q: Can I take BPC-157 with IGF-1 LR3?

Yes, BPC-157 and IGF-1 LR3 can generally be taken together. Complementary healing mechanisms.

Q: Is BPC-157 and IGF-1 LR3 safe together?

Based on documented research, this combination is considered synergistic. However, shared safety flags include: carcinogenic risk. Monitor accordingly.

Q: What are the interactions between BPC-157 and IGF-1 LR3?

Complementary healing mechanisms. This assessment has 95% confidence and is based on documented research data.

Q: How should I time BPC-157 and IGF-1 LR3?

BPC-157 has a half-life of <30 minutes and IGF-1 LR3 has a half-life of 20-30 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Synergistic

Researched 95% confidence

BPC-157 and IGF-1 LR3 have a synergistic interaction with 95% confidence. Complementary healing mechanisms. Both compounds affect the blood vessels, so monitoring these systems is recommended.

Compound Profiles

BPC-157

Body Protection Compound-157 | Pentadecapeptide

Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..

Half-life: <30 minutes Typical dose: 250-500mcg healing, longevity

vegf anticoagulantcarcinogenic riskpro angiogenicteratogenic

View full profile

IGF-1 LR3

Modified Growth Factor Analog | Muscle Growth

Functions as a full IGF-1 receptor agonist activating PI3K/Akt/mTOR and MAPK/ERK pathways. The modifications prevent protein sequestration, maintaining elevated free circulating levels for extended anabolic effects.

Half-life: 20-30 hours Typical dose: 20-100 mcg daily (start low at 20-30 mcg) growth hormone, healing

igf1mtor carcinogenic riskinsulin disrupting

View full profile

Combined Organ Load

Blood Vessels

low

Pituitary

low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (BPC-157, IGF-1 LR3). Monitor accordingly.

Frequently Asked Questions

Can I take BPC-157 with IGF-1 LR3?

Yes, BPC-157 and IGF-1 LR3 can generally be taken together. Complementary healing mechanisms.

Is BPC-157 and IGF-1 LR3 safe together?

Based on documented research, this combination is considered synergistic. However, shared safety flags include: carcinogenic risk. Monitor accordingly.

What are the interactions between BPC-157 and IGF-1 LR3?

Complementary healing mechanisms. This assessment has 95% confidence and is based on documented research data.

How should I time BPC-157 and IGF-1 LR3?

BPC-157 has a half-life of <30 minutes and IGF-1 LR3 has a half-life of 20-30 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: BPC-157 vs IGF-1 LR3

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.